Prostate Cancer International is a
non-profit for 2012 as rated by Great NonProfits
Two “pro” and “con” commentaries appeared on line this week in the Journal of Urology under the heading “Focal therapy will become standard treatment for localized prostate cancer.” .. READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: con, focal therapy, outcome, pro | 1 Comment »
It is well understood that current Western screening and diagnostic processes commonly identify patients with low volume, low Gleason grade prostate cancer tumors (e.g., a single biopsy core with < 10 percent of the core positive for cancer of Gleason score 3 + 3 = 6). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: candidate, focal therapy, incidence, risk, selection | 12 Comments »
For several years, various research teams have been assessing the potential of focal therapy as a means to treat carefully selected men with localized prostate cancer. However, to date, the ability to identify such men with accuracy prior to such treatment is still in question. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: focal therapy, multifocal, outcome, unifocal | 5 Comments »
To date there have been few data from well-documented, prospective series of patients receiving any form of focal therapy as treatment for localized prostate cancer, and the criteria for the appropriate clinical use of focal therapy are still a matter of considerable debate. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: focal therapy, hemiablative, HIFU, high-intensity focused ultrasound, outcome | 6 Comments »
Historically, “success” in the treatment of localized prostate cancer was the elimination of all evidence of cancer from the patient’s prostate and other nearby tissues — through radical surgery or radiation therapy of some type. But the increasing acceptance of active surveillance and the evolution of focal forms of therapy have introduced whole new ways of thinking about the “successful” management of low- and even intermediate-risk, localized disease. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: active surveillance, control, cure, focal therapy, risk | 4 Comments »
In a presentation given at the annual meeting of the American Urology Association earlier this year, researchers from Memorial Sloan-Kettering Cancer Center (MSKCC) provided some interesting data on the natural history of prostate cancer in patients initially diagnosed with low-risk disease. … READ MORE …
Filed under: Uncategorized | Tagged: active surveillance, focal therapy, low risk, natural history, outcome | 3 Comments »
… after you pass away, this is the sort of study that you may be able to watch it be used for (always assuming that there is actually a life after death and that you have the ability to observe what happens to your prior “vessel”). … READ MORE …
Filed under: Management, Treatment | Tagged: ablation, focal therapy, laser | 4 Comments »
In today’s news reports we note new articles dealing with:
Filed under: Diagnosis, Management, Living with Prostate Cancer, Treatment, Drugs in development | Tagged: Gleason, tertiary, bisphosphonate, focal therapy, dasatinib, denosumab, zoledronate, saracatinib | 7 Comments »
This weekend’s news report includes items on:
Filed under: Living with Prostate Cancer, Management, Risk, Treatment | Tagged: active surviellance, biopsy, cores, focal therapy, progression, PSA, radical prostatectomy, ultrasensitive | Leave a Comment »
An article in this week’s New England Journal of Medicine has argued that an earlier report, postulating the monoclonal origin of lethal metastatic prostate cancer, increases the justification for focal therapy for early stage prostate cancer. … READ MORE …
Filed under: Management, Treatment | Tagged: focal therapy, origin | 3 Comments »
Today’s news reports deal with items on:
Filed under: Drugs in development, Management, Prevention, Treatment | Tagged: arc, bitter melon, focal therapy, hypofractionated, intensity-modulated, radiotherapy, reconstruction, sulforaphane, urinary tract | Leave a Comment »
Dr. Aaron Katz has been practicing cryotherapy at Columbia University Medical Center in New York since 1993, so one could reasonably expect him to have a sophisticated appreciation for the pros and cons of this technique. … READ MORE …
Filed under: Management, Treatment | Tagged: cryotherapy, focal therapy, localized | Leave a Comment »
Today’s reports address:
Filed under: Diagnosis, Management, Treatment | Tagged: bias, elevated PSA, focal therapy, Italy, T3 disease, training | Leave a Comment »
Today’s news reports cover such matters as:
Filed under: Diagnosis, Management, Prevention, Risk, Treatment | Tagged: focal therapy, gene expression signature, genistein, imaging | Leave a Comment »
In today’s news report we touch on papers that address:
Filed under: Living with Prostate Cancer, Management, Prevention, Risk, Treatment | Tagged: 5α-reductase inhibitor, focal therapy, genome, marker, Prevention, risk, selenium, SNP, targeted | Leave a Comment »
Search for new and
ongoing trials on the
CTAG PCa web site